CCIWA Call (888) 217-1376 24/7 confidential

Vivitrol Providers Directory

Vivitrol is the brand name for extended-release naltrexone, a once-monthly intramuscular injection that treats both opioid use disorder and alcohol use disorder. Unlike Suboxone or methadone, it does not require a federally certified opioid treatment program to administer. That changes where you can get it and what to expect at the appointment.

6,318
SAMHSA-listed Vivitrol facilities
52
States, DC, and Puerto Rico covered
589
Cities with 3+ providers
What this directory is. Every listing comes from the 2025 SAMHSA National Substance Use and Mental Health Services Survey (N-SUMHSS) directory, filtered for facilities reporting the VTRL service code (Vivitrol administration). SAMHSA listings are self-reported. Phone status, current address, and confirmed in-office injection capability still need to be checked before any clinical decision. We mark which providers we have verified directly.

Top 10 states by Vivitrol facility count

Coverage tracks population and Medicaid expansion footprint, not need. New York, California, Ohio, Pennsylvania, and Florida lead in raw counts. Per-capita density tells a different story, and we surface that on each state page.

Source: 2025 SAMHSA N-SUMHSS National Directory. Filtered on VTRL service code.
Rank State Vivitrol facilities Density
#1 New York 465
#2 California 457
#3 Ohio 375
#4 Pennsylvania 312
#5 Florida 281
#6 Kentucky 279
#7 Arizona 267
#8 Maryland 244
#9 Indiana 224
#10 Illinois 219

What Vivitrol actually is

Vivitrol is a 380mg dose of naltrexone suspended in microspheres, injected into the gluteal muscle every four weeks. Naltrexone is an opioid antagonist. It blocks the mu-opioid receptors that opioids bind to and that alcohol indirectly stimulates. No agonist activity, no withdrawal mitigation, no opioid effect at all.

That makes Vivitrol fundamentally different from Suboxone or methadone. Both of those medications are opioid agonists. They occupy the same receptors that heroin or oxycodone do, just more slowly and predictably. Naltrexone does the opposite. It evicts opioids from the receptor and prevents them from working. Try to use heroin on Vivitrol and nothing happens, until the shot wears off.

Why the difference matters

Two practical implications:

  1. You have to be opioid-free for 7 to 10 days before the first injection. Naltrexone in an opioid-dependent person triggers precipitated withdrawal almost immediately. This is the single biggest barrier to Vivitrol uptake for opioid use disorder.
  2. Any licensed prescriber can order it and any clinical office can administer it. There is no federal certification requirement, no DEA waiver, no special licensing. That is why the Vivitrol provider universe is much wider than the methadone or buprenorphine universe, and why the directory you are looking at has 6,318 entries instead of the few hundred OTPs that dispense methadone.

Find Vivitrol providers by state

Compare Vivitrol against other treatments

Vivitrol is one option in a small set of FDA-approved medications for opioid and alcohol use disorder. Picking the right one depends on your goals, your medical history, and your living situation. These guides walk through the tradeoffs.

Cost and access guides

Methodology

All facility counts come from the 2025 SAMHSA National Directory of Drug and Alcohol Use Treatment Facilities, the public-use file released by the Substance Abuse and Mental Health Services Administration based on the 2024 N-SUMHSS survey. We filter on the VTRL service code, which indicates the facility reports administering or prescribing Vivitrol.

Vivitrol provider acceptance into our verified directory requires four gates: SAMHSA listing, live phone status, geocoded street address, and confirmed in-office intramuscular administration. SAMHSA-listed providers without complete verification appear on state hubs as references but do not get individual clinic profile pages. See our methodology for the full data pipeline and update cadence.

Data source: 2025 SAMHSA N-SUMHSS National Directory of Drug and Alcohol Use Treatment Facilities. Released March 2026, covers 2024 survey year. Last directory build: 2026-05-04.